MDXG Stock Analysis: Buy, Sell, or Hold?
MDXG - MiMedx Group, Inc
$3.60
-0.09 (-2.44%)
▼
5d:
-2.17%
30d:
-10.67%
90d:
-30.1%
BUY
HIGH Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Smart Money Distribution
MDXG is up 7.3% this week, but smart money is buying puts. Top strike: $2.5 2026-06-18 with 100 OI. Put ratio: 100% View Scanner →
Strength: 8.6/10
Get Alerted When MDXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MDXG shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: MDXG shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: MDXG is currently trading at $3.60, which is considered fair relative to its 30-day fair value range of $3.36 to $3.91. From a valuation perspective, the stock is trading at a premium (Forward PE: 29.4) compared to its historical average (26.1). At these levels, the market is pricing in 4.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MDXG is in a strong downtrend. Immediate support is located at $3.02, while resistance sits at $3.73.
Market Sentiment: MDXG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.50 (+80.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MDXG is in a strong downtrend. Immediate support is located at $3.02, while resistance sits at $3.73.
Market Sentiment: MDXG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.50 (+80.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.36 -
$3.91
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 80.6% below Wall St target ($6.50)
- NEUTRAL: Market pricing in 4.0% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$3.36 -
$3.91
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.03
Resistance Level
$3.73
Current Trend
Strong Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
29.39
Wall Street Target
$6.50
(+80.6%)
Revenue Growth (YoY)
-33.1%
Earnings Growth (YoY)
99.5%
Profit Margin
7.9%
Valuation Premium vs History
+4.0% premium
PE vs Historical
29.4 vs 26.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.0%
(market-implied from PE analysis)
1-Year Target
$3.74
(+4%)
2-Year Target
$3.89
(+8%)
3-Year Target
$4.05
(+13%)
3-Yr Target (if PE normalizes)
(PE: 29→26)
PE COMPRESSION
$3.60
(0%)
Earnings growth offset by PE compression
📈
Valuation based on Current Earnings
Trailing PE: 18.45 | Current EPS (TTM): $0.20
Bull Case
$2.49
(-31%)
Analyst growth -38.8%, PE expands to 20.3
Base Case
$2.26
(-37%)
Market implied -38.8%, PE stable at 18.5
Bear Case
$2.51
(-30%)
Severe decline -20.0%, PE contracts to 15.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 10, 2026 12:30 PM ET
Data refreshes hourly during market hours. Next update: 1:30 PM
Data refreshes hourly during market hours. Next update: 1:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 57 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 69 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$104 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 58 HOLD |
